Mucus Relief Tablet
NDC Package 62795-1012-2
Package Information
Mucus Relief (antimony potassium tartrate, atropa belladonna, bryonia alba whole, anemone americana, hyoscyamus niger, ipecac, lobelia inflata, human sputum, bordetella pertussis infected, and lobaria pulmonaria) tablets is at first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. This formulation utilizes a tablet delivery system. Marketed by Medinatura Inc, this product is identified by NDC 62795-1012.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62795 - Medinatura Inc
- 62795-1012 - Mucus Relief
- 62795-1012-2 - 100 TABLET in 1 BOTTLE
- 62795-1012 - Mucus Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (62795-1012). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62795-1012-2 identifies a specific commercial package of 100 tablet in 1 bottle of Mucus Relief, a human over the counter drug labeled by Medinatura Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains anemone hepatica var. obtusa; antimony potassium tartrate; atropa belladonna; bryonia alba whole; human sputum, bordetella pertussis infected; hyoscyamus niger; ipecac; lobaria pulmonaria; lobelia inflata as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medinatura Inc on January 01, 2015. The current certification is valid through December 31, 2026.
How is this Medinatura Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62795101202. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.